BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2023 7:57:45 AM | Browse: 315 | Download: 722
 |
Received |
|
2023-03-22 11:09 |
|
Peer-Review Started |
|
2023-03-22 11:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-04-10 11:25 |
|
Revised |
|
2023-06-07 19:06 |
|
Second Decision |
|
2023-06-21 02:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-06-21 08:09 |
|
Articles in Press |
|
2023-06-21 08:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-06-19 04:00 |
|
Typeset the Manuscript |
|
2023-06-29 09:18 |
|
Publish the Manuscript Online |
|
2023-07-12 07:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Probiotics and autoprobiotics for treatment of Helicobacter pylori infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Natalia V Baryshnikova, Anastasia S Ilina, Elena I Ermolenko, Yury P Uspenskiy and Alexander N Suvorov |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Natalia V Baryshnikova, MD, PhD, Associate Professor, Senior Lecturer, Department of Molecular Microbiology, Institute of Experimental Medicine, Pavlova, 12A, St. Petersburg 197376, Russia. baryshnikova_nv@mail.ru |
| Key Words |
Helicobacter pylori; Probiotic; Autoprobiotic; Eradication; Microbiota; Gut; Immunity |
| Core Tip |
The usage of probiotics in complex eradication therapy holds promise for optimizing the treatment of Helicobacter pylori (H. pylori) infection. Probiotics have the potential to enhance the eradication rate of H. pylori, reduce the frequency and severity of side effects, and improve patient compliance. Probiotic and autoprobiotic monotherapies are viable alternatives in cases of allergic reactions or adverse effects caused by antibiotics, owing to their direct antagonistic effect on H. pylori. However, conducting new randomized multicenter studies is necessary to investigate the intricate effects of probiotics and autoprobiotics against H. pylori infection, with the aim of gaining a better understanding of their mechanisms of action. |
| Publish Date |
2023-07-12 07:57 |
| Citation |
Baryshnikova NV, Ilina AS, Ermolenko EI, Uspenskiy YP, Suvorov AN. Probiotics and autoprobiotics for treatment of Helicobacter pylori infection. World J Clin Cases 2023; 11(20): 4740-4751 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i20/4740.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i20.4740 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
